Decreased interleukin-18 response in asthmatic children with severe Mycoplasma pneumoniae pneumonia

Hai Lee Chung1, Jin Young Shin, Mi Ju

  • 1Department of Pediatrics, School of Medicine, Catholic University of Taegu, Taegu, South Korea. hlchung@cu.ac.kr

Cytokine
|March 2, 2011
PubMed
Abstract

Insights

Asthmatic children with Mycoplasma pneumoniae pneumonia showed reduced Interleukin-18 (IL-18) and CXCL10 responses, correlating with more severe symptoms. This suggests a deficient IL-18 response may contribute to worse outcomes in these patients.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Respiratory Medicine

Background:

  • Mycoplasma pneumoniae is a frequent cause of childhood pneumonia.
  • Asthma is a common chronic respiratory condition in children.
  • Understanding immune responses in pediatric pneumonia is crucial for effective treatment.

Purpose of the Study:

  • To compare cytokine and chemokine responses in asthmatic versus non-asthmatic children with acute M. pneumoniae pneumonia.
  • To investigate the relationship between immune mediators and symptom severity in pediatric M. pneumoniae pneumonia.
  • To identify potential differences in immune profiles that could explain varied clinical outcomes.

Main Methods:

  • Seventy-five children (6-12 years) with M. pneumoniae pneumonia were divided into asthmatic (N=40) and non-asthmatic (N=35) groups.
  • Plasma levels of Interleukin-18 (IL-18) and chemokines (IL-8, CXCL9, CXCL10, RANTES) were measured using ELISA.
  • Comparison of mediator levels and symptom severity between asthmatic and non-asthmatic patients, with 20 controls.

Main Results:

  • Patients with M. pneumoniae pneumonia had significantly elevated IL-18 and chemokines compared to controls.
  • Asthmatic children exhibited significantly lower IL-18 and CXCL10 levels.
  • Asthmatic patients presented with more severe pneumonia symptoms, and lower IL-18 levels correlated with severity.

Conclusions:

  • IL-18 and chemokines play a role in the pathogenesis of M. pneumoniae pneumonia.
  • Asthmatic children may have a deficient IL-18 response during M. pneumoniae infection.
  • This deficient response could be linked to the increased pneumonia severity observed in asthmatic children.

Related Concept Videos

Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma III: Clinical Manifestations01:13

Asthma III: Clinical Manifestations

Asthma presents with a characteristic pattern of episodic respiratory symptoms that reflect underlying airway inflammation, bronchoconstriction, and mucus hypersecretion. Although severity varies among individuals, certain clinical manifestations are considered hallmarks of the disorder and often guide diagnosis and assessment.Respiratory SymptomsA persistent cough is one of the most common early features of asthma. It is frequently dry and tends to worsen at night or in the early morning,...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...